Next-Generation ALK Inhibitors in Non-Small Cell Lung Cancer
2 Pogledi
administrator
07/14/23
Experts discuss the next-generation ALK inhibitors ceritinib and AP26113 as treatments for patients with non-small cell lung cancer.
For more from this discussion, visit http://www.onclive.com/peer-exchange/nsclc-needs
Prikaži više
Komentari na Facebooku
Nema komentara